fleroxacin has been researched along with Dysentery, Bacillary in 2 studies
Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.
Dysentery, Bacillary: DYSENTERY caused by gram-negative rod-shaped enteric bacteria (ENTEROBACTERIACEAE), most often by the genus SHIGELLA. Shigella dysentery, Shigellosis, is classified into subgroups according to syndrome severity and the infectious species. Group A: SHIGELLA DYSENTERIAE (severest); Group B: SHIGELLA FLEXNERI; Group C: SHIGELLA BOYDII; and Group D: SHIGELLA SONNEI (mildest).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A clinical study was conducted on fleroxacin (FLRX) in 143 patients and carriers with infectious enteritis (shigellosis, Salmonella enteritis, Campylobacter enteritis, pathogenic Escherichia coli enteritis, Vibrio parahaemolyticus enteritis, cholera, multiple bacterial infections, pathogen-negative enteritis)." | 9.07 | [Basic and clinical studies of fleroxacin on infectious enteritis. Research Group of AM-833 on infectious enteritis]. ( Ajisawa, A; Masuda, G; Murata, M; Negishi, M; Nitta, Y; Sagara, H; Takizawa, Y; Tomizawa, I; Tsunoda, T; Yamaguchi, T, 1994) |
| "A clinical study was conducted on fleroxacin (FLRX) in 143 patients and carriers with infectious enteritis (shigellosis, Salmonella enteritis, Campylobacter enteritis, pathogenic Escherichia coli enteritis, Vibrio parahaemolyticus enteritis, cholera, multiple bacterial infections, pathogen-negative enteritis)." | 5.07 | [Basic and clinical studies of fleroxacin on infectious enteritis. Research Group of AM-833 on infectious enteritis]. ( Ajisawa, A; Masuda, G; Murata, M; Negishi, M; Nitta, Y; Sagara, H; Takizawa, Y; Tomizawa, I; Tsunoda, T; Yamaguchi, T, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sagara, H | 1 |
| Tomizawa, I | 1 |
| Takizawa, Y | 1 |
| Nitta, Y | 1 |
| Tsunoda, T | 1 |
| Yamaguchi, T | 1 |
| Masuda, G | 1 |
| Negishi, M | 1 |
| Ajisawa, A | 1 |
| Murata, M | 1 |
| Zhao, M | 1 |
| Jiang, S | 1 |
| Wang, R | 1 |
1 trial available for fleroxacin and Dysentery, Bacillary
| Article | Year |
|---|---|
[Basic and clinical studies of fleroxacin on infectious enteritis. Research Group of AM-833 on infectious enteritis].
Topics: Adolescent; Adult; Aged; Campylobacter Infections; Drug Administration Schedule; Dysentery, Bacillar | 1994 |
1 other study available for fleroxacin and Dysentery, Bacillary
| Article | Year |
|---|---|
[The serum bactericidal activity of domestic fleroxacin and lomefloxacin].
Topics: Anti-Infective Agents; Dysentery, Bacillary; Escherichia coli; Fleroxacin; Fluoroquinolones; Humans; | 1999 |